Comparison of in vitro tests for antioxidant and immunomodulatory capacities of compounds

Phytomedicine

Volumn 21, Issue 2, 2014, Pages 164-171

  Becker, Kathrin ^a   Schroecksnadel, Sebastian ^a   Gostner, Johanna ^a   Zaknun, Cathrine ^a   Schennach, Harald ^b   Überall, Florian ^a   Fuchs, Dietmar ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b UNIVERSITY HOSPITAL INNSBRUCK   (Austria)

Author keywords

Cell based antioxidant activity (CAA); Immunomodulation; In vitro test systems; Inflammation; Oxidative stress; Oxygen radical absorbance capacity (ORAC) assay; Peripheral blood mononuclear cells; Reactive oxygen species

Indexed keywords

ANTIINFLAMMATORY AGENT; ANTIOXIDANT; BIOLOGICAL MARKER; NEOPTERIN; PEROXY RADICAL; PLANT EXTRACT; TRYPTOPHAN;

AGING; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; ASSAY; CAA ASSAY; DENDRITIC CELL; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; IN VITRO STUDY; MACROPHAGE; ORAC ASSAY; OXIDATIVE STRESS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL;

ANTIOXIDANT RESPONSE ELEMENT; ARE; CAA; CELL-BASED ANTIOXIDANT ACTIVITY; CELL-BASED ANTIOXIDANT ACTIVITY (CAA); GTP-CH1; GTP-CYCLOHYDROLASE I; IDO; IFN-Γ; IL-2; IMMUNOMODULATION; IN VITRO TEST SYSTEMS; INDOLEAMINE 2,3-DIOXYGENASE; INDUCIBLE NITRIC OXIDE SYNTHASE; INFLAMMATION; INOS; INTERFERON-GAMMA; INTERLEUKINE-2; KYN/TRP; KYNURENINE TO TRYPTOPHAN RATIO; NF-ΚB; NITRIC OXIDE; NO; NUCLEAR FACTOR-ΚB; ORAC; OXIDATIVE STRESS; OXYGEN RADICAL ABSORBANCE CAPACITY; OXYGEN RADICAL ABSORBANCE CAPACITY (ORAC) ASSAY; PBMC; PERIPHERAL BLOOD MONONUCLEAR CELLS; REACTIVE OXYGEN SPECIES; ROS; TNF-Α; TUMOR NECROSIS FACTOR-ALPHA;

ANTI-INFLAMMATORY AGENTS; ANTIOXIDANTS; HUMANS; IMMUNOLOGIC FACTORS; INFLAMMATION; LEUKOCYTES, MONONUCLEAR; LIPOPOLYSACCHARIDES; MITOGENS; MODELS, BIOLOGICAL; NEOPTERIN; OXIDATIVE STRESS; PLANT EXTRACTS; REACTIVE OXYGEN SPECIES; TRYPTOPHAN;

EID: 84892918615     PISSN: 09447113     EISSN: 1618095X     Source Type: Journal    
DOI: 10.1016/j.phymed.2013.08.008     Document Type: Article

References (80)

1. S.L. Albarracin, B. Stab, Z. Casas, J.J. Sutachan, I. Samudio, J. Gonzalez, L. Gonzalo, F. Capani, L. Morales, and G.E. Barreto Effects of natural antioxidants in neurodegenerative disease Nutr. Neurosci. 15 2012 1 9
2. B.B. Aggarwal Nuclear factor-kappaB: the enemy within Cancer Cell 6 2004 203 208
3. P.J. Andrew, and B. Mayer Enzymatic function of nitric oxide synthases Cardiovasc. Res. 43 1999 521 531
4. K. Asehnoune, D. Strassheim, S. Mitra, J.Y. Kim, and E. Abraham Involvement of reactive oxygen species in Toll-like receptor 4-dependent activation of NF-kappa B J. Immunol. 172 2004 2522 2529
5. K. Balakrishnan, and L.E. Adams The role of the lymphocyte in an immune response Immunol. Invest. 24 1995 233 244
6. H. Barth, P.A. Berg, and R. Klein Methods for the in vitro determination of an individual disposition towards TH1- or TH2-reactivity by the application of appropriate stimulatory antigens Clin. Exp. Immunol. 134 2003 78 85
7. I.F. Benzie, and J.J. Strain The ferric reducing ability of plasma (FRAP) as a measure of "antioxidant power": the FRAP assay Anal. Biochem. 239 1996 70 76
8. R.P. Bowler, and J.D. Crapo Oxidative stress in allergic respiratory diseases J. Allergy Clin. Immunol. 110 2002 349 356
9. A. Boyum Isolation of leucocytes from human blood: further observations - methylcellulose, dextran and Ficoll as erythrocyte aggregating agents Scand. J. Clin. Lab. Invest. Suppl. 97 1968 31 50
10. M.S. Butt, and M.T. Sultan Green tea: nature's defense against malignancies Crit. Rev. Food Sci. Nutr. 49 2009 463 473
11. G.I. Byrne, L.K. Lehmann, J.G. Kirschbaum, E.C. Borden, C.M. Lee, and R.R. Brown Induction of tryptophan degradation in vitro and in vivo: a gamma-interferon-stimulated activity J. Interferon Res. 6 1986 389 396
12. S. Chuchawankul, N. Khorana, and Y. Poovorawan Piperine inhibits cytokine production by human peripheral blood mononuclear cells Genet. Mol. Res. 11 2012 617 627
13. K.J. Davies Oxidative stress, antioxidant defenses, and damage removal, repair, and replacement systems IUBMB Life 50 2000 279 289
14. S. De Rosa, P. Cirillo, M. Pacileo, G. Petrillo, G.L. D'Ascoli, F. Maresca, F. Ziviello, and M. Chiariello Neopterin: from forgotten biomarker to leading actor in cardiovascular pathophysiology Curr. Vasc. Pharmacol. 9 2011 188 199
15. 2+-stimulated ATP production in human complex I deficiency J. Mol. Med. (Berl.) 87 2009 515 522
16. S. Egert, and G. Rimbach Which sources of flavonoids: complex diets or dietary supplements? Adv. Nutr. 2 2011 8 14
17. S. Ellinger, N. Müller, P. Stehle, and G. Ulrich-Merzenich Consumption of green tea or green tea products: is there an evidence for antioxidant effects from controlled interventional studies? Phytomedicine 18 2011 903 915
18. E.M. Eugui, B. DeLustro, S. Rouhafza, M. Ilnicka, S.W. Lee, R. Wilhelm, and A.C. Allison Some antioxidants inhibit, in a co-ordinate fashion, the production of tumor necrosis factor-alpha, IL-beta, and IL-6 by human peripheral blood mononuclear cells Int. Immunol. 6 1994 409 422
19. B. Frick, K. Schroecksnadel, G. Neurauter, F. Leblhuber, and D. Fuchs Increasing production of homocysteine and neopterin and degradation of tryptophan with older age Clin. Biochem. 37 2004 684 687
20. D. Fuchs, A. Hausen, G. Reibnegger, E.R. Werner, M.P. Dierich, and H. Wachter Neopterin as a marker for activated cell-mediated immunity: application in HIV infection Immunol. Today 9 1988 150 155
21. D. Fuchs, A.A. Möller, G. Reibnegger, E.R. Werner, G. Werner-Felmayer, M.P. Dierich, and H. Wachter Increased endogenous interferon-gamma and neopterin correlate with increased degradation of tryptophan in human immunodeficiency virus type 1 infection Immunol. Lett. 28 1991 207 211
22. D. Fuchs, G. Weiss, G. Reibnegger, and H. Wachter The role of neopterin as a monitor of cellular immune activation in transplantation, inflammatory, infectious, and malignant diseases Crit. Rev. Clin. Lab. Sci. 29 1992 307 341
23. D. Fuchs, P. Avanzas, R. Arroyo-Espliguero, M. Jenny, L. Consuegra-Sanchez, and J.C. Kaski The role of neopterin in atherogenesis and cardiovascular risk assessment Curr. Med. Chem. 16 2009 4644 4653
24. R. Hattori, R. Inoue, K. Sase, H. Eizawa, K. Kosuga, T. Aoyama, H. Masayasu, C. Kawai, S. Sasayama, and Y. Yui Preferential inhibition of inducible nitric oxide synthase by ebselen Eur. J. Pharmacol. 267 1994 R1 R2
25. E. Heiss, C. Herhaus, K. Klimo, H. Bartsch, and C. Gerhauser Nuclear factor kappa B is a molecular target for sulforaphane-mediated anti-inflammatory mechanisms J. Biol. Chem. 276 2001 32008 32015
26. S. Hori, T. Nomura, and S. Sakaguchi Control of regulatory T cell development by the transcription factor Foxp3 Science 299 2003 1057 1061
27. K. Itoh, T. Chiba, S. Takahashi, T. Ishii, K. Igarashi, Y. Katoh, T. Oyake, N. Hayashi, K. Satoh, I. Hatayama, M. Yamamoto, and Y. Nabeshima An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements Biochem. Biophys. Res. Commun. 236 1997 313 322
28. H. Iwagaki, A. Hizuta, N. Tanaka, and K. Orita Decreased serum tryptophan in patients with cancer cachexia correlates with increased serum neopterin Immunol. Invest. 24 1995 467 478
29. M. Jenny, M. Klieber, D. Zaknun, S. Schroecksnadel, K. Kurz, M. Ledochowski, H. Schennach, and D. Fuchs In vitro testing for anti-inflammatory properties of compounds employing peripheral blood mononuclear cells freshly isolated from healthy donors Inflamm. Res. 60 2011 127 135
30. M. Jenny, E. Santer, A. Klein, M. Ledochowski, H. Schennach, F. Ueberall, and D. Fuchs Cacao extracts suppress tryptophan degradation of mitogen-stimulated peripheral blood mononuclear cells J. Ethnopharmacol. 122 2009 261 267
31. M. Jenny, E. Santer, E. Pirich, H. Schennach, and D. Fuchs Delta9-tetrahydrocannabinol and cannabidiol modulate mitogen-induced tryptophan degradation and neopterin formation in peripheral blood mononuclear cells in vitro J. Neuroimmunol. 207 2009 75 82
32. B. Jin, T. Sun, X.H. Yu, Y.X. Yang, and A.E. Yeo The effects of TLR activation on T-cell development and differentiation Clin. Dev. Immunol. 2012 2012 836485
33. N. Juge, R.F. Mithen, and M. Traka Molecular basis for chemoprevention by sulforaphane: a comprehensive review Cell. Mol. Life Sci. 64 2007 1105 1127
34. J.W. Kaspar, S.K. Niture, and A.K. Jaiswal Antioxidant-induced INrf2 (Keap1) tyrosine 85 phosphorylation controls the nuclear export and degradation of the INrf2-Cul3-Rbx1 complex to allow normal Nrf2 activation and repression J. Cell Sci. 125 2012 1027 1038
35. D.R. Lucey, M. Clerici, and G.M. Shearer Type 1 and type 2 cytokine dysregulation in human infectious, neoplastic, and inflammatory diseases Clin. Microbiol. Rev. 9 1996 532 562
36. E. Maier, K. Kurz, M. Jenny, H. Schennach, F. Ueberall, and D. Fuchs Food preservatives sodium benzoate and propionic acid and colorant curcumin suppress Th1-type immune response in vitro Food Chem. Toxicol. 48 2010 1950 1956
37. J.D. Milner, D.M. Stein, R. McCarter, and R.Y. Moon Early infant multivitamin supplementation is associated with increased risk for food allergy and asthma Pediatrics 114 2004 27 32
38. D.H. Munn, E. Shafizadeh, J.T. Attwood, I. Bondarev, A. Pashine, and A.L. Mellor Inhibition of T cell proliferation by macrophage tryptophan catabolism J. Exp. Med. 189 1999 1363 1372
39. C. Murr, L.C. Fuith, B. Widner, B. Wirleitner, G. Baier-Bitterlich, and D. Fuchs Increased neopterin concentrations in patients with cancer: indicator of oxidative stress? Anticancer Res. 19 1999 1721 1728
40. C. Murr, K. Schroecksnadel, C. Winkler, M. Ledochowski, and D. Fuchs Antioxidants may increase the probability of developing allergic diseases and asthma Med. Hypotheses 64 5 2005 973 977
41. C. Murr, B. Widner, B. Wirleitner, and D. Fuchs Neopterin as a marker for immune system activation Curr. Drug Metab. 3 2002 175 187
42. C. Murr, B.M. Winklhofer-Roob, K. Schroecksnadel, M. Maritschnegg, H. Mangge, B.O. Bohm, B.R. Winkelmann, W. Marz, and D. Fuchs Inverse association between serum concentrations of neopterin and antioxidants in patients with and without angiographic coronary artery disease Atherosclerosis 202 2009 543 549
43. C.F. Nathan Peroxide and pteridine: a hypothesis on the regulation of macrophage antimicrobial activity by interferon gamma Interferon 7 1986 125 143
44. G. Neurauter, B. Wirleitner, A. Laich, H. Schennach, G. Weiss, and D. Fuchs Atorvastatin suppresses interferon-gamma-induced neopterin formation and tryptophan degradation in human peripheral blood mononuclear cells and in monocytic cell lines Clin. Exp. Immunol. 131 2003 264 267
45. B. Ou, M. Hampsch-Woodill, and R.L. Prior Development and validation of an improved oxygen radical absorbance capacity assay using fluorescein as the fluorescent probe J. Agric. Food Chem. 49 2001 4619 4626
46. J.M. Planas, I. Alfaras, H. Colom, and M.E. Juan The bioavailability and distribution of trans-resveratrol are constrained by ABC transporters Arch. Biochem. Biophys. 527 2012 67 73
47. P.D. Ray, B.W. Huang, and Y. Tsuji Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling Cell. Signal. 24 2012 981 990
48. S. Romagnani Immunologic influences on allergy and the TH1/TH2 balance J. Allergy Clin. Immunol. 113 2004 395 400
49. S. Romagnani Regulation of the T cell response Clin. Exp. Allergy. 36 November 2006 1357 1366
50. B. Schmidt, D.M. Ribnicky, A. Poulev, S. Logendra, W.T. Cefalu, and I- Raskin A natural history of botanical therapeutics Metabolism 57 2008 S3 S9
51. K. Schroecksnadel, B. Fischer, H. Schennach, G. Weiss, and D. Fuchs Antioxidants suppress Th1-type immune response in vitro Drug Metab. Lett. 1 2007 166 171
52. K. Schroecksnadel, C. Winkler, B. Wirleitner, H. Schennach, and D. Fuchs Aspirin down-regulates tryptophan degradation in stimulated human peripheral blood mononuclear cells in vitro Clin. Exp. Immunol. 140 2005 41 45
53. K. Schroecksnadel, C. Winkler, L.C. Fuith, and D. Fuchs Tryptophan degradation in patients with gynecological cancer correlates with immune activation Cancer Lett. 223 2005 323 329
54. K. Schroecksnadel, B. Wirleitner, C. Winkler, and D. Fuchs Monitoring tryptophan metabolism in chronic immune activation Clin. Chim. Acta 364 2006 82 90
55. S. Schroecksnadel, M. Jenny, K. Kurz, A. Klein, M. Ledochowski, F. Uberall, and D. Fuchs LPS-induced NF-kappaB expression in THP-1Blue cells correlates with neopterin production and activity of indoleamine 2,3-dioxygenase Biochem. Biophys. Res. Commun. 399 2010 642 646
56. S. Schroecksnadel, C. Zaknun, H. Schennach, M. Jenny, and D. Fuchs Comparison of in vitro tests for antioxidant capacities and immunomodulatory properties of chemicals J. Bionanosci. 6 2012 1 7
57. D. Singh, A. Aggarwal, R. Maurya, and S. Naik Withania somnifera inhibits NF-kappaB and AP-1 transcription factors in human peripheral blood and synovial fluid mononuclear cells Phytother. Res. 21 2007 905 913
58. S.V. Singh, S.K. Srivastava, S. Choi, K.L. Lew, J. Antosiewicz, D. Xiao, Y. Zeng, S.C. Watkins, C.S. Johnson, D.L. Trump, Y.J. Lee, H. Xiao, and A. Herman-Antosiewicz Sulforaphane-induced cell death in human prostate cancer cells is initiated by reactive oxygen species J. Biol. Chem. 280 2005 19911 19924
59. S.T. Smale Hierarchies of NF-κB target-gene regulation Nat. Immunol. 12 2011 689 694
60. Y.J. Surh, J.K. Kundu, and H.K. Na Nrf2 as a master redox switch in turning on the cellular signaling involved in the induction of cytoprotective genes by some chemopreventive phytochemicals Planta Med. 74 2008 1526 1539
61. V. Tamasi, J.M. Jeffries, G.E. Arteel, and K.C. Falkner Ebselen augments its peroxidase activity by inducing nrf-2-dependent transcription Arch. Biochem. Biophys. 431 2004 161 168
62. A.C. Terentis, M. Freewan, T.S. Sempertegui Plaza, M.J. Raftery, R. Stocker, and S.R. Thomas The selenazal drug ebselen potently inhibits indoleamine 2,3-dioxygenase by targeting enzyme cysteine residues Biochemistry 49 2010 591 600
63. S. Ueda, H. Masutani, H. Nakamura, T. Tanaka, M. Ueno, and J. Yodoi Redox control of cell death Antioxid. Redox Signal. 4 2002 405 414
64. D. Vauzour, M. Buonfiglio, G. Corona, J. Chirafisi, K. Vafeiadou, C. Angeloni, S. Hrelia, P. Hrelia, and J.P. Spencer Sulforaphane protects cortical neurons against 5-S-cysteinyl-dopamine-induced toxicity through the activation of ERK1/2, Nrf-2 and the upregulation of detoxification enzymes Mol. Nutr. Food Res. 54 2010 532 542
65. G. Weiss, D. Fuchs, A. Hausen, G. Reibnegger, E.R. Werner, G. Werner-Felmayer, E. Semenitz, M.P. Dierich, and H. Wachter Neopterin modulates toxicity mediated by reactive oxygen and chloride species FEBS Lett. 321 1993 89 92
66. E.R. Werner, G. Werner-Felmayer, D. Fuchs, A. Hausen, G. Reibnegger, and H. Wachter Parallel induction of tetrahydrobiopterin biosynthesis and indoleamine 2,3-dioxygenase activity in human cells and cell lines by interferon-gamma Biochem. J. 262 1989 861 866
67. E.R. Werner, G. Werner-Felmayer, D. Fuchs, A. Hausen, G. Reibnegger, J.J. Yim, W. Pfleiderer, and H. Wachter Tetrahydrobiopterin biosynthetic activities in human macrophages, fibroblasts, THP-1, and T 24 cells. GTP-cyclohydrolase I is stimulated by interferon-gamma, and 6-pyruvoyl tetrahydropterin synthase and sepiapterin reductase are constitutively present J. Biol. Chem. 265 1990 3189 3192
68. G. Werner-Felmayer, E.R. Werner, D. Fuchs, A. Hausen, G. Reibnegger, and H. Wachter Neopterin formation and tryptophan degradation by a human myelomonocytic cell line (THP-1) upon cytokine treatment Cancer Res. 1990 50 1990 2863 2867
69. B. Widner, E.R. Werner, H. Schennach, H. Wachter, and D. Fuchs Simultaneous measurement of serum tryptophan and kynurenine by HPLC Clin. Chem. 43 1997 2424 2426
70. B. Widner, B. Wirleitner, G. Baier-Bitterlich, G. Weiss, and D. Fuchs Cellular immune activation, neopterin production, tryptophan degradation and the development of immunodeficiency Arch. Immunol. Ther. Exp. (Warsz.) 48 2000 251 258
71. B. Widner, F. Leblhuber, J. Walli, G.P. Tilz, U. Demel, and D. Fuchs Tryptophan degradation and immune activation in Alzheimer's disease J. Neural Transm. 107 2000 343 353
72. B. Widner, F. Leblhuber, and D. Fuchs Increased neopterin production and tryptophan degradation in advanced Parkinson's disease J. Neural Transm. 109 2002 181 189
73. C. Winkler, K. Schroecksnadel, H. Schennach, and D. Fuchs Vitamin C and E suppress mitogen-stimulated peripheral blood mononuclear cells in vitro Int. Arch. Allergy Immunol. 142 2007 127 132
74. C. Winkler, B. Wirleitner, K. Schroecksnadel, H. Schennach, and D. Fuchs St. John's wort (Hypericum perforatum) counteracts cytokine-induced tryptophan catabolism in vitro Biol. Chem. 385 2004 1197 1202
75. B.M. Winklhofer-Roob, E. Rock, J. Ribalta, D.H. Shmerling, and J.M. Roob Effects of vitamin E and carotenoid status on oxidative stress in health and disease. Evidence obtained from human intervention studies Mol. Aspects Med. 24 2003 391 402
76. A.M. Wolf, D. Wolf, H. Rumpold, A.R. Moschen, A. Kaser, P. Obrist, D. Fuchs, G. Brandacher, C. Winkler, K. Geboes, P. Rutgeerts, and H. Tilg Overexpression of indoleamine 2,3-dioxygenase in human inflammatory bowel disease Clin. Immunol. 113 2004 47 55
77. K.L. Wolfe, and R.H. Liu Cellular antioxidant activity (CAA) assay for assessing antioxidants, foods, and dietary supplements J. Agric. Food Chem. 55 2007 8896 8907
78. J.J. Yu, and S.L. Gaffen Interleukin-17: a novel inflammatory cytokine that bridges innate and adaptive immunity Front. Biosci. 13 2008 170 177 Review
79. D. Zaknun, S. Schroecksnadel, K. Kurz, and D. Fuchs Potential role of antioxidant food supplements, preservatives and colorants in the pathogenesis of allergy and asthma Int. Arch. Allergy Immunol. 157 2012 113 124
80. E. Zvetkova, B. Wirleitner, N.T. Tram, H. Schennach, and D. Fuchs Aqueous extracts of Crinum latifolium (L.) and Camellia sinensis show immunomodulatory properties in human peripheral blood mononuclear cells Int. Immunopharmacol. 1 2001 2143 2150